Page 30 - Read Online

local chemotherapeutic agents, also enhancing the effects embolization/chemoembolization (TAE/TACE) for the treatment of
of anticancer agents on cancer cells by the hyperthermia single hepatocellular carcinoma. World J Gastroenterol 2007;13:2952-5.
following RFA. So our conclusion is combined RFA and TACE 16. N’Kontchou G, Mahamoudi A, Aout M, Ganne-Carrié N, Grando V,
Coderc E, Vicaut E, Trinchet JC, Sellier N, Beaugrand M, Seror O.
appear to be effective modality and superior to TACE alone Radiofrequency ablation of hepatocellular carcinoma: long-term results
for the treatment of HCC and prognostic factors in 235 Western patients with cirrhosis. Hepatology
2009;50:1475-83.
17. Takaki H, Yamakado K, Nakatsuka A, Fuke H, Murata K, Shiraki K,
REFERENCES Takeda K. Radiofrequency ablation combined with chemoembolization
for the treatment of hepatocellular carcinomas 5 cm or smaller: risk
1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. factors for local tumor progression. J Vasc Interv Radiol 2007;18:856-61.
CA Cancer J Clin 2005;55:74-108. 18. Rhim H, Lim HK, Choi D. Current status of radiofrequency ablation of
2. el-Zayadi AR, Badran HM, Barakat EM, Attia Mel-D, Shawky S, hepatocellular carcinoma. World J Gastrointest Surg 2010;2:128-36.
Mohamed MK, Selim O, Saeid A. Hepatocellular carcinoma in Egypt: a 19. Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H,
single center study over a decade. World J Gastroenterol 2005;11:5193-8. Isaji S, Shiraki K, Fuke H, Uemoto S, Takeda K. Early-stage
3. McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current hepatocellular carcinoma: radiofrequency ablation combined with
status. AJR Am J Roentgenol 2001;176:3-16. chemoembolization versus hepatectomy. Radiology 2008;247:260-6.
4. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, 20. Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ,
Gazelle GS. Hepatocellular carcinoma: radio-frequency ablation of Lau WY. A case-control study comparing percutaneous radiofrequency
medium and large lesions. Radiology 2000;214:761-8. ablation alone or combined with transcatheter arterial chemoembolization
5. Janis and Friends, Hepatitis C Support web site, Liver Cancer; 2008. for hepatocellular carcinoma. Eur J Surg Oncol 2010;36:257-63.
Available from: http://www.janisandfriendshepatitiscsupport.com. [Last 21. Wang YH, Liu JF, Li F, Li A, Liu Q, Liu DB, Liu DG, Wang YJ.
accessed on 2012 Oct 1]. Radiofrequency ablation combined with transarterial chemoembolization
6. Kurokohchi K, Watanabe S, Masaki T, Hosomi N, Funaki T, Arima K, for unresectable primary liver cancer. Chin Med J (Engl) 2009;122:889-94.
Yoshida S, Miyauchi Y, Kuriyama S. Combined use of percutaneous 22. Takaki H, Yamakado K, Uraki J, Nakatsuka A, Fuke H, Yamamoto N,
ethanol injection and radiofrequency ablation for the effective treatment Shiraki K, Yamada T, Takeda K. Radiofrequency ablation combined
of hepatocelluar carcinoma. Int J Oncol 2002;21:841-6. with chemoembolization for the treatment of hepatocellular carcinomas
7. Bruix J, Sherman M. Practice Guidelines Committee, American larger than 5 cm. J Vasc Interv Radiol 2009;20:217-24.
Association for the Study of Liver Diseases. Management of 23. Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, Yi CH.
hepatocellular carcinoma. Hepatology 2005;42:1208-36. Chemoembolization combined with radiofrequency ablation for patients
8. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet with hepatocellular carcinoma larger than 3 cm: a randomized controlled
2003;362:1907-17. trial. JAMA 2008;299:1669-77.
9. Mallick I. What is the performance status? Health Disease and Condition 24. Sacco R, Bertini M, Petruzzi P, Bertoni M, Bargellini I, Bresci G, Federici G,
Content is reviewed by the Medical Review Board; 2007. Available Gambardella L, Metrangolo S, Parisi G, Romano A, Scaramuzzino A,
from: http://www.About.com. [Last accessed on 2012 Oct 1]. Tumino E, Silvestri A, Altomare E, Vignali C, Capria A. Clinical impact
10. Mor E, Tur-Kaspa R, Sheiner P, Schwartz M. Treatment of hepatocellular of selective transarterial chemoembolization on hepatocellular carcinoma:
carcinoma associated with cirrhosis in the era of liver transplantation. a cohort study. World J Gastroenterol 2009;15:1843-8.
Ann Intern Med 1998;129:643-53. 25. Kim JH, Won HJ, Shin YM, Kim SH, Yoon HK, Sung KB, Kim PN.
11. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial
Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma chemoembolization plus radiofrequency ablation versus radiofrequency
and prognosis in relation to treatment. Study of 850 patients. Cancer ablation alone. Ann Surg Oncol 2011;18:1624-9.
1985;56:918-28. 26. Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N,
12. Al Knawy B, Reddy KR, Bolondi L, editors. Preface. In: Hepatocellular Watanabe T, Mine T; Tokai RFA Study Group. Transcatheter arterial
Carcinoma: a practical approach. United Kingdom: Informa Healthcare; chemoembolization plus radiofrequency ablation therapy for early stage
2009. hepatocellular carcinoma: comparison with surgical resection. Cancer
13. Velázquez RF, Rodríguez M, Navascués CA, Linares A, Pérez R, 2010;116:3638-44.
Sotorríos NG, Martínez I, Rodrigo L. Prospective analysis of risk factors
for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology
2003;37:520-7. How to cite this article: El Dorry AK, Fathy Barakat EM, Abd ElMoez AT,
Fatah Mawad MA, El-Fouly NF, Shaker MK. Combined radiofrequency and
14. Llovet JM, Bruix J. Systematic review of randomized trials for chemoembolization vs. chemoembolization in management of hepatocellular
unresectable hepatocellular carcinoma: chemoembolization improves carcinoma. Hepatoma Res 2015;1:19-23.
survival. Hepatology 2003;37:429-42.
15. Miraglia R, Pietrosi G, Maruzzelli L, Petridis I, Caruso S, Marrone G, Source of Support: Nil. Confl ict of Interest: None declared.
Mamone G, Vizzini G, Luca A, Gridelli B. Effi cacy of transcatheter

Hepatoma Research | Volume 1 | Issue 1 | April 15, 2015 23